JR7 sp. z o.o.sp. k.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-10-26
Limited partner contribution
2,000.00 PLN
Registered address
ul. Modlińska 191F, 05-135 Wieliszew, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 89 days late).

  • 202530/03/2026
  • 202420/03/2025
  • 202314/03/2024
  • 202226/06/2023
  • 202112/10/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.13mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 37.76kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 1.09mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 475.68kMedianUSD 543.65kAverageUSD 1.76m

Partners

PartnersPartner role
General partner
Monika Mikuczonisage 48
General partner

Manner of representation

The general partner independently – JR7 spółka z ograniczoną odpowiedzialnością with its registered office in Wieliszew, method of representation of the general partner: each member of the management board is authorised to represent the company independently – management board consisting of: President of the Management Board Monika Mikuczonis – PESEL ***********

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-12-10.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 511

Public aid

5 public aid cases recorded, with a total value of $12,040.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,515
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,923
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,845

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2026-04-13Address change
2015-10-26Entered in the register

FAQ

Last updated: 2026-04-13